FdaApplication
ANDA 217197
Identifiers
- fda_app_no: ANDA217197
Properties
| Property | Value |
|---|---|
| applicant_name | NE RX PHARMA LLC |
| application_type | ANDA |
| approval_date | 2023-05-09 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ACETAZOLAMIDE | ACETAZOLAMIDE | 250MG | TABLET;ORAL |
| ACETAZOLAMIDE | ACETAZOLAMIDE | 125MG | TABLET;ORAL |
2 products